Skip to content

Clinical trials

Completed Phase 3 Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Phase 3 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20051
20072
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academic and Community Cancer Research United1
ETOP IBCSG Partners Foundation1
Eastern Cooperative Oncology Group1
Georgetown University1
INSYS Therapeutics Inc1
NSABP Foundation Inc1
North Central Cancer Treatment Group1
Queen Mary University of London1
Radiation Therapy Oncology Group1
Regional Oncologic Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ11
Breast Neoplasms11
Carcinoma, Intraductal, Noninfiltrating7
Breast Neoplasms, Male2
Carcinoma, Ductal, Breast2
Endometrial Neoplasms2
Hot Flashes2
Adrenocortical Carcinoma1
Anus Neoplasms1
Appendiceal Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.